Integral Health Asset Management, LLC Intra Cellular Therapies, Inc. Transaction History

Integral Health Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $1.3 Million - $1.6 Million	20,000 Added 16.0%	145,000 $9.93 Million
Q1 2024 May 15, 2024	SELL	$64.37 - $75.65 $3.22 Million - $3.78 Million	-50,000 Reduced 28.57%	125,000 $8.65 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $1.95 Million - $3.09 Million	42,000 Added 31.58%	175,000 $12.5 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $468,810 - $576,900	-9,000 Reduced 6.34%	133,000 $6.93 Million
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $7.76 Million - $9.43 Million	142,000 New	142,000 $8.99 Million
Q2 2022 Aug 03, 2022	BUY	$43.0 - $65.64 $1.65 Million - $2.51 Million	38,277 Added 95.69%	78,277 $4.47 Million
Q1 2022 May 12, 2022	BUY	$38.74 - $62.09 $1.55 Million - $2.48 Million	40,000 New	40,000 $2.45 Million
Q1 2021 May 10, 2021	SELL	$30.8 - $39.51 $924,000 - $1.19 Million	-30,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $1.63 Million - $2.26 Million	-70,000 Reduced 70.0%	30,000 $954,000
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $1.76 Million - $3.19 Million	100,000 New	100,000 $2.57 Million

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.